Sung‐Han Kim
Impact in
- Infectious Diseases top 0.1%
- Antimicrobial Resistance in Staphylococcus
- SARS-CoV-2 and COVID-19 Research
- Antifungal resistance and susceptibility
- Tuberculosis Research and Epidemiology
Papers in
-
- Antimicrobial Resistance in Staphylococcus 52
- SARS-CoV-2 and COVID-19 Research 51
- Antifungal resistance and susceptibility 37
- Tuberculosis Research and Epidemiology 35
- COVID-19 Clinical Research Studies 34
- Epidemiology 173
- Co-authors
- Sang‐Ho Choi (251 shared papers)Jun Hee Woo (193 shared papers)Yang Soo Kim (240 shared papers)Hong Bin Kim (40 shared papers)Sang‐Oh Lee (235 shared papers)Kang Won Choe (37 shared papers)Myoung‐don Oh (37 shared papers)Cheol‐In Kang (15 shared papers)
- Journals
- Journal of Korean Medical Science (27 papers)Open Forum Infectious Diseases (21 papers)European Journal of Clinical Microbiology & Infectious Diseases (19 papers)Antimicrobial Agents and Chemotherapy (18 papers)Clinical Infectious Diseases (18 papers)
- Partner nations
- South KoreaUnited StatesEthiopia
In The Last Decade
Sung‐Han Kim
584 papers receiving 14.2k citations
Sung‐Han Kim's Hit Papers
Peers
Comparison fields: 5 of 196
- Applied Microbiology and Biotechnology 543
- Infectious Diseases 4.9k
- Molecular Medicine 1.3k
- Clinical Biochemistry 1.1k
- Epidemiology 3.8k
Countries citing papers authored by Sung‐Han Kim
This map shows the geographic impact of Sung‐Han Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sung‐Han Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sung‐Han Kim more than expected).
Fields of papers citing papers by Sung‐Han Kim
This network shows the impact of papers produced by Sung‐Han Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sung‐Han Kim. The network helps show where Sung‐Han Kim may publish in the future.
Co-authors
The 25 scholars most cited alongside Sung‐Han Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 625 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19 Hit paper breakdown → | 2020 | 549 |
| 2 | Bloodstream Infections Caused by Antibiotic-Resistant Gram-Negative Bacilli: Risk Factors for Mortality and Impact of Inappropriate Initial Antimicrobial Therapy on Outcome Hit paper breakdown → | 2005 | 546 |
| 3 | Early Surgery versus Conventional Treatment for Infective Endocarditis Hit paper breakdown → | 2012 | 544 |
| 4 | 2003 | 456 | |
| 5 | Metasurface-driven OLED displays beyond 10,000 pixels per inch Hit paper breakdown → | 2020 | 322 |
| 6 | Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19 Hit paper breakdown → | 2020 | 270 |
| 7 | 2007 | 242 | |
| 8 | 2005 | 238 | |
| 9 | 2004 | 223 | |
| 10 | 2003 | 196 | |
| 11 | 2016 | 190 | |
| 12 | 2015 | 140 | |
| 13 | 2015 | 138 | |
| 14 | 2007 | 120 | |
| 15 | 2007 | 116 | |
| 16 | 2015 | 111 | |
| 17 | 2003 | 110 | |
| 18 | Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor Hit paper breakdown → | 2024 | 107 |
| 19 | 2015 | 102 | |
| 20 | 2006 | 102 |
About Sung‐Han Kim
Sung‐Han Kim is a scholar working on Infectious Diseases, Epidemiology, Surgery, Molecular Biology and Clinical Biochemistry, having authored 625 papers that have together received 14.5k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (52 papers), SARS-CoV-2 and COVID-19 Research (51 papers), Antibiotic Resistance in Bacteria (44 papers), Bacterial Identification and Susceptibility Testing (44 papers), Antifungal resistance and susceptibility (37 papers), Infectious Diseases and Tuberculosis (36 papers), Tuberculosis Research and Epidemiology (35 papers) and COVID-19 Clinical Research Studies (34 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (543 citations), Infectious Diseases (4.9k citations), Molecular Medicine (1.3k citations), Clinical Biochemistry (1.1k citations) and Epidemiology (3.8k citations). Sung‐Han Kim has collaborated with scholars based in South Korea, United States and Ethiopia. Frequent co-authors include Sang‐Ho Choi, Jun Hee Woo, Yang Soo Kim, Hong Bin Kim, Sang‐Oh Lee, Kang Won Choe, Myoung‐don Oh, Cheol‐In Kang, Wan Beom Park and Jiwon Jung. Their work appears in journals such as Journal of Korean Medical Science, Open Forum Infectious Diseases, European Journal of Clinical Microbiology & Infectious Diseases, Antimicrobial Agents and Chemotherapy and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.